======= ETFB =======
== Gene Information ==
* **Official Symbol**: ETFB
* **Official Name**: electron transfer flavoprotein subunit beta
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2109|2109]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P38117|P38117]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ETFB&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ETFB|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/130410|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes electron-transfer-flavoprotein, beta polypeptide, which shuttles electrons between primary flavoprotein dehydrogenases involved in mitochondrial fatty acid and amino acid catabolism and the membrane-bound electron transfer flavoprotein ubiquinone oxidoreductase. The gene deficiencies have been implicated in type II glutaricaciduria. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Heterodimeric electron transfer flavoprotein that accepts electrons from several mitochondrial dehydrogenases, including acyl-CoA dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase (PubMed:25416781, PubMed:15159392, PubMed:15975918). It transfers the electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (Probable). Required for normal mitochondrial fatty acid oxidation and normal amino acid metabolism (PubMed:12815589, PubMed:7912128). ETFB binds an AMP molecule that probably has a purely structural role (PubMed:8962055, PubMed:15159392, PubMed:15975918). {ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:25416781, ECO:0000269|PubMed:7912128, ECO:0000269|PubMed:8962055, ECO:0000303|PubMed:17941859, ECO:0000305}.
|ETF|
|fatty acid beta-oxidation using acyl-CoA dehydrogenase|
|fatty acid beta-oxidation|
|electron transfer activity|
|fatty acid oxidation|
|lipid oxidation|
|fatty acid catabolic process|
|respiratory electron transport chain|
|monocarboxylic acid catabolic process|
|cellular respiration|
|electron transport chain|
|cellular lipid catabolic process|
|lipid modification|
|energy derivation by oxidation of organic compounds|
|carboxylic acid catabolic process|
|organic acid catabolic process|
|lipid catabolic process|
|fatty acid metabolic process|
|mitochondrial matrix|
|generation of precursor metabolites and energy|
|small molecule catabolic process|
|monocarboxylic acid metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|lipid metabolic process|
|mitochondrion|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-2.38|
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-2.1|
|[[:results:exp539|42°C R08 exp539]]|-2.02|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.98|
|[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.87|
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.75|
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.73|
|[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.72|
|[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|1.73|
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.81|
|[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.84|
|[[:results:exp332|Adefovir 20μM R07 exp332]]|1.96|
|[[:results:exp463|Caffeine 2600μM R08 exp463]]|2.02|
|[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|2.22|
|[[:results:exp480|ETC-159 50μM R08 exp480]]|2.47|
^Gene^Correlation^
|[[:human genes:e:etfa|ETFA]]|0.42|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8882
* **Expression level (log2 read counts)**: 5.27
{{:chemogenomics:nalm6 dist.png?nolink |}}